Genetic mutations can alter how the proteins produced by our genes function and can lead to diseases like cancer. Now researchers have used the gene-editing technology CRISPR/Cas 9 in a less commonly ...
Hosted on MSN
CRISPR-based gene editing revolutionized medicine—the company that helped develop it says that's just the beginning
Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this revolution is CRISPR Therapeutics. I’ve been a couples therapist for 30 years: Any ...
SAN DIEGO--(BUSINESS WIRE)--iXCells Biotechnologies (“iXCells” or the “Company”), a provider of cell products and drug discovery services to the worldwide academic, biotech and pharmaceutical ...
The first in-human trial of a CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood within 6 months.
In December 2020, the New England Journal of Medicine published a paper titled CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia, marking an exciting new chapter in the treatment of ...
Scientists have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors. A revolution in biomedicine is currently underway, driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback